Lee Biosolutions Manufactures   Myeloperoxidase  and CRP, Key Prognostic Markers of Inflammation of  Cardiovascular Disease

ST. LOUIS , MO  Lee Biosolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Myeloperoxidase isolated from Leukocytes and C-Reactive Protein from Pleural Fluid.   The St. Louis-based  biotechnology firm has  developed a unique  proprietary process to effectively and efficiently purify  the  Myeloperoxidase and C-Reactive Protein  used in the prediction of Cardiovascular Disease. As a result, Lee is now is a preferred producer for researchers and  diagnostic companies to supply these critical components .

According to the Centers of Disease and Control, over 40% of all deaths in the United States are attributed to Cardiovascular Disease which means over 1 million of us die every year.  Several risk factors are used by doctors to determine the risk of developing CVC and what better way to access an individual than to test and predict that they will have cardiovascular disease.

LeeBio’s new  Myeloperoxidase and C-Reactive Protein production capabilities enables international diagnostics companies  to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Cardiovascular  research  by supplying  highly purified  markers such as C-Reactive Protein and  Myeloperoxidase .  “ said Burton Lee, President of Lee Biosolutions  . “  You will find the future of clinical diagnostics will utilize a greater number of  combination of biomarkers to predict early clinical diagnosis of diseases as they are identified.”

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished  human proteins.  Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein (HDL), CkMB and Troponin,  The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit www.LeeBio.com or call 314-968-1091.